International Clinical Trial: Clinical Evaluation and Investigation of the Type I Interferon Pathway in Anti-MDA5-Positive Dermatomyositis-Associated Interstitial Lung Disease Based on Multimodal Ultrasound

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128655) titled 'Clinical Evaluation and Investigation of the Type I Interferon Pathway in Anti-MDA5-Positive Dermatomyositis-Associated Interstitial Lung Disease Based on Multimodal Ultrasound' on July 23.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Peking University People's Hospital

Condition: Idiopathic inflammatory myopathies

Intervention: Idiopathic inflammatory myopathy without interstitial lung disease group:None Idiopathic inflammatory myopathy without interstitial lung disease group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-07-30

Target...